APA (7th ed.) Citation

An, N., Li, J., Luo, P., Wang, D., Zhang, P., Shu, C., . . . Li, C. (2025). Key predictors of long-term outcomes in BCMA-targeted CAR-T therapy for relapsed/refractory multiple myeloma. Journal of Translational Medicine, 23(1), 1. https://doi.org/10.1186/s12967-025-06543-x

Chicago Style (17th ed.) Citation

An, Ning, et al. "Key Predictors of Long-term Outcomes in BCMA-targeted CAR-T Therapy for Relapsed/refractory Multiple Myeloma." Journal of Translational Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12967-025-06543-x.

MLA (9th ed.) Citation

An, Ning, et al. "Key Predictors of Long-term Outcomes in BCMA-targeted CAR-T Therapy for Relapsed/refractory Multiple Myeloma." Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12967-025-06543-x.